Bioinformatics Research and Applications: 18th International Symposium, ISBRA 2022, Haifa, Israel, November 14-17, 2022, Proceedings

This book presents the proceedings of the 18th International Symposium on Bioinformatics Research and Applications, ISBRA 2022, which includes 30 full papers and 4 short papers on various bioinformatics topics such as AI and disease, computational proteomics, biomedical imaging, drug screening, and sequencing data analysis.

Format: Paperback / softback
Length: 390 pages
Publication date: 02 January 2023
Publisher: Springer International Publishing AG

The 18th International Symposium on Bioinformatics Research and Applications, ISBRA 2022, was a remarkable event that took place in Haifa, Israel, from November 14 to 17, 2022. This symposium brought together a diverse group of experts from around the world to explore the latest advancements and applications in bioinformatics.

The conference featured a total of 30 full papers and 4 short papers, which were meticulously reviewed and selected from a pool of 72 submissions. These papers were organized into topical sections, including:

AI and Disease: This section explored the intersection of artificial intelligence (AI) and disease, focusing on how AI can be used to diagnose, treat, and prevent various diseases.

Computational Proteomics: This section focused on the analysis of protein sequences and structures using computational methods, with a particular emphasis on identifying protein biomarkers and understanding protein-protein interactions.

Biomedical Imaging: This section covered the use of imaging techniques, such as MRI, CT, and PET, to diagnose and treat diseases, as well as to study biological processes.

Drug Screening and Drug-Drug Interaction Prediction: This section explored the use of bioinformatics methods to predict drug-drug interactions and identify potential drug candidates.

Biomedical Data: This section dealt with the management, analysis, and interpretation of large biomedical datasets, including genomics, proteomics, and clinical data.

Sequencing Data Analysis: This section focused on the analysis of next-generation sequencing data, including DNA and RNA sequencing, to identify genetic mutations, gene expression patterns, and other biological insights.

The presentations and discussions at ISBRA 2022 covered a wide range of topics, from theoretical developments to practical applications, and provided valuable insights into the future of bioinformatics research and applications. The symposium also featured a poster session, where researchers showcased their latest research findings and interacted with fellow attendees.

Overall, ISBRA 2022 was a successful event that facilitated the exchange of knowledge and ideas between researchers and practitioners in the field of bioinformatics. The contributions made by the participants and speakers at this symposium will undoubtedly have a significant impact on the future of this rapidly evolving field.

The 18th International Symposium on Bioinformatics Research and Applications, ISBRA 2022, was a remarkable event that took place in Haifa, Israel, from November 14 to 17, 2022. This symposium brought together a diverse group of experts from around the world to explore the latest advancements and applications in bioinformatics.

The conference featured a total of 30 full papers and 4 short papers, which were meticulously reviewed and selected from a pool of 72 submissions. These papers were organized into topical sections, including:

AI and Disease: This section explored the intersection of artificial intelligence (AI) and disease, focusing on how AI can be used to diagnose, treat, and prevent various diseases.

Computational Proteomics: This section focused on the analysis of protein sequences and structures using computational methods, with a particular emphasis on identifying protein biomarkers and understanding protein-protein interactions.

Biomedical Imaging: This section covered the use of imaging techniques, such as MRI, CT, and PET, to diagnose and treat diseases, as well as to study biological processes.

Drug Screening and Drug-Drug Interaction Prediction: This section explored the use of bioinformatics methods to predict drug-drug interactions and identify potential drug candidates.

Biomedical Data: This section dealt with the management, analysis, and interpretation of large biomedical datasets, including genomics, proteomics, and clinical data.

Sequencing Data Analysis: This section focused on the analysis of next-generation sequencing data, including DNA and RNA sequencing, to identify genetic mutations, gene expression patterns, and other biological insights.

The presentations and discussions at ISBRA 2022 covered a wide range of topics, from theoretical developments to practical applications, and provided valuable insights into the future of bioinformatics research and applications. The symposium also featured a poster session, where researchers showcased their latest research findings and interacted with fellow attendees.

Overall, ISBRA 2022 was a successful event that facilitated the exchange of knowledge and ideas between researchers and practitioners in the field of bioinformatics. The contributions made by the participants and speakers at this symposium will undoubtedly have a significant impact on the future of this rapidly evolving field.

The 18th International Symposium on Bioinformatics Research and Applications, ISBRA 2022, was a remarkable event that took place in Haifa, Israel, from November 14 to 17, 2022. This symposium brought together a diverse group of experts from around the world to explore the latest advancements and applications in bioinformatics.

The conference featured a total of 30 full papers and 4 short papers, which were meticulously reviewed and selected from a pool of 72 submissions. These papers were organized into topical sections, including:

AI and Disease: This section explored the intersection of artificial intelligence (AI) and disease, focusing on how AI can be used to diagnose, treat, and prevent various diseases.

Computational Proteomics: This section focused on the analysis of protein sequences and structures using computational methods, with a particular emphasis on identifying protein biomarkers and understanding protein-protein interactions.

Biomedical Imaging: This section covered the use of imaging techniques, such as MRI, CT, and PET, to diagnose and treat diseases, as well as to study biological processes.

Drug Screening and Drug-Drug Interaction Prediction: This section explored the use of bioinformatics methods to predict drug-drug interactions and identify potential drug candidates.

Biomedical Data: This section dealt with the management, analysis, and interpretation of large biomedical datasets, including genomics, proteomics, and clinical data.

Sequencing Data Analysis: This section focused on the analysis of next-generation sequencing data, including DNA and RNA sequencing, to identify genetic mutations, gene expression patterns, and other biological insights.

The presentations and discussions at ISBRA 2022 covered a wide range of topics, from theoretical developments to practical applications, and provided valuable insights into the future of bioinformatics research and applications. The symposium also featured a poster session, where researchers showcased their latest research findings and interacted with fellow attendees.

Overall, ISBRA 2022 was a successful event that facilitated the exchange of knowledge and ideas between researchers and practitioners in the field of bioinformatics. The contributions made by the participants and speakers at this symposium will undoubtedly have a significant impact on the future of this rapidly evolving field.

The 18th International Symposium on Bioinformatics Research and Applications, ISBRA 2022, was a remarkable event that took place in Haifa, Israel, from November 14 to 17, 2022. This symposium brought together a diverse group of experts from around the world to explore the latest advancements and applications in bioinformatics.

The conference featured a total of 30 full papers and 4 short papers, which were meticulously reviewed and selected from a pool of 72 submissions. These papers were organized into topical sections, including:

AI and Disease: This section explored the intersection of artificial intelligence (AI) and disease, focusing on how AI can be used to diagnose, treat, and prevent various diseases.

Computational Proteomics: This section focused on the analysis of protein sequences and structures using computational methods, with a particular emphasis on identifying protein biomarkers and understanding protein-protein interactions.

Biomedical Imaging: This section covered the use of imaging techniques, such as MRI, CT, and PET, to diagnose and treat diseases, as well as to study biological processes.

Drug Screening and Drug-Drug Interaction Prediction: This section explored the use of bioinformatics methods to predict drug-drug interactions and identify potential drug candidates.

Biomedical Data: This section dealt with the management, analysis, and interpretation of large biomedical datasets, including genomics, proteomics, and clinical data.

Sequencing Data Analysis: This section focused on the analysis of next-generation sequencing data, including DNA and RNA sequencing, to identify genetic mutations, gene expression patterns, and other biological insights.

The presentations and discussions at ISBRA 2022 covered a wide range of topics, from theoretical developments to practical applications, and provided valuable insights into the future of bioinformatics research and applications. The symposium also featured a poster session, where researchers showcased their latest research findings and interacted with fellow attendees.

Overall, ISBRA 2022 was a successful event that facilitated the exchange of knowledge and ideas between researchers and practitioners in the field of bioinformatics. The contributions made by the participants and speakers at this symposium will undoubtedly have a significant impact on the future of this rapidly evolving field.

The 18th International Symposium on Bioinformatics Research and Applications, ISBRA 2022, was a remarkable event that took place in Haifa, Israel, from November 14 to 17, 2022. This symposium brought together a diverse group of experts from around the world to explore the latest advancements and applications in bioinformatics.

The conference featured a total of 30 full papers and 4 short papers, which were meticulously reviewed and selected from a pool of 72 submissions. These papers were organized into topical sections, including:

AI and Disease: This section explored the intersection of artificial intelligence (AI) and disease, focusing on how AI can be used to diagnose, treat, and prevent various diseases.

Computational Proteomics: This section focused on the analysis of protein sequences and structures using computational methods, with a particular emphasis on identifying protein biomarkers and understanding protein-protein interactions.

Biomedical Imaging: This section covered the use of imaging techniques, such as MRI, CT, and PET, to diagnose and treat diseases, as well as to study biological processes.

Drug Screening and Drug-Drug Interaction Prediction: This section explored the use of bioinformatics methods to predict drug-drug interactions and identify potential drug candidates.

Biomedical Data: This section dealt with the management, analysis, and interpretation of large biomedical datasets, including genomics, proteomics, and clinical data.

Sequencing Data Analysis: This section focused on the analysis of next-generation sequencing data, including DNA and RNA sequencing, to identify genetic mutations, gene expression patterns, and other biological insights.

The presentations and discussions at ISBRA 2022 covered a wide range of topics, from theoretical developments to practical applications, and provided valuable insights into the future of bioinformatics research and applications. The symposium also featured a poster session, where researchers showcased their latest research findings and interacted with fellow attendees.

Overall, ISBRA 2022 was a successful event that facilitated the exchange of knowledge and ideas between researchers and practitioners in the field of bioinformatics. The contributions made by the participants and speakers at this symposium will undoubtedly have a significant impact on the future of this rapidly evolving field.

Weight: 617g
Dimension: 235 x 155 (mm)
ISBN-13: 9783031231971
Edition number: 1st ed. 2022